Puma Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBYI and other ETFs, options, and stocks.

About PBYI

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. 

CEO
Alan H. Auerbach
CEOAlan H. Auerbach
Employees
172
Employees172
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2010
Founded2010
Employees
172
Employees172

PBYI Key Statistics

Market cap
347.65M
Market cap347.65M
Price-Earnings ratio
8.91
Price-Earnings ratio8.91
Dividend yield
Dividend yield
Average volume
389.96K
Average volume389.96K
High today
$7.00
High today$7.00
Low today
$6.55
Low today$6.55
Open price
$6.64
Open price$6.64
Volume
603.21K
Volume603.21K
52 Week high
$7.00
52 Week high$7.00
52 Week low
$2.58
52 Week low$2.58

Stock Snapshot

Puma Biotechnology(PBYI) stock is priced at $7.00, giving the company a market capitalization of 347.65M. It carries a P/E multiple of 8.91.

During the trading session on 2026-01-21, Puma Biotechnology(PBYI) shares reached a daily high of $7.00 and a low of $6.55. At a current price of $7.00, the stock is +7.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 603.21K, compared to an average daily volume of 389.96K.

The stock's 52-week range extends from a low of $2.58 to a high of $7.00.

The stock's 52-week range extends from a low of $2.58 to a high of $7.00.

People also own

Based on the portfolios of people who own PBYI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.